Product Information
Price Revision for Denka Chloroprene
IR Information
Notice Regarding Results of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)
Announcement of Extraordinary Gains (Gain on Sale of Investment Securities)
Summary of Q&A Session for Management Presentation on Feb 27 2026
News
Denka Recognized as a “KENKO Investment for Health Outstanding Organization (large enterprise category ~White 500~)” for the Fourth Consecutive Year
Notice Concerning Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary)
Presentation Materials for Management Presentation on Feb 27 2026 with Script